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The direct effect of a rotavirus nonstructural glycoprotein, NSP4, and certain related peptides on the
sodium-coupled transport of D-glucose and of L-leucine was studied by using intestinal brush border membrane
vesicles isolated from young rabbits. Kinetic analyses revealed that the NSP4(114-135) peptide, which causes
diarrhea in young rodents, is a specific, fully noncompetitive inhibitor of the Na1-D-glucose symporter
(SGLT1). This interaction involves three peptide-binding sites per carrier unit. In contrast, the Norwalk virus
NV(464-483) and mNSP4(131K) peptides, neither of which causes diarrhea, both behave inertly. The
NSP4(114-135) and NV(464-483) peptides inhibited Na1-L-leucine symport about equally and partially via a
different transport mechanism, in that Na1 behaves as a nonobligatory activator. The selective and strong
inhibition caused by the NSP4(114-135) peptide on SGLT1 in vitro suggests that during rotavirus infection in
vivo, NSP4 can be one effector directly causing SGLT1 inhibition. This effect, implying a concomitant inhibition
of water reabsorption, is postulated to play a mechanistic role in the pathogenesis of rotavirus diarrhea.
A rotavirus nonstructural glycoprotein, NSP4, and a syn-
thetic peptide, NSP4(114-135), corresponding to residues 114
to 135 of this protein, both have been shown to induce age- and
dose-dependent diarrhea in young rodents (5). Because the
induction of diarrhea and alterations in chloride secretion,
unaccompanied by any histological lesions, occurred within a
period of about 3 h, similar to those induced by the heat-stable
toxin b of Escherichia coli, NSP4 was proposed to be a viral
enterotoxin which, by activating a Ca21-dependent signal
transduction pathway, impairs intestinal epithelial transport
(5). However, it is known that the ionic concentrations in the
stools of rotavirus-infected animals, although high, are consid-
erably less than those occurring in the secretory diarrheas
caused by secretagogues such as the enterotoxins of Vibrio
cholerae and E. coli (11, 15). Since the mechanisms by which
rotavirus and NSP4 cause diarrhea are not completely under-
stood, investigating possible, alternative mechanisms might
prove useful. Recently, others have shown that rotavirus infec-
tion alters regulation of the expression of digestive enzymes
(13).
Independently, we have demonstrated that both natural and
experimental infection by a lapine group A rotavirus, La/
RR510 strain, isolated in our laboratory impairs Na1-D-glu-
cose (SGLT1) and Na1-L-leucine symport activity across intes-
tinal brush border membrane (BBM) vesicles isolated from
young rabbits. Because infection reduces D-glucose transport
capacity (Vmax) without affecting the density of phlorizin-bind-
ing sites and of SGLT1 protein antigen present in the BBM
vesicles, we concluded that the rotavirus effect on this sym-
porter is direct (10). Transport inhibition preceded viral shed-
ding into the lumen and the onset of diarrhea. No intestinal
lesion was seen in the experimentally infected rabbits, confirm-
ing that diarrhea is not necessarily a consequence of the intes-
tinal lesion but can precede it, as if cell dysfunction were the
cause, not the consequence, of the histological damage (5, 6,
10, 17, 18, 22).
Since SGLT1 is involved in the reabsorption of large vol-
umes of water under physiological conditions, we proposed
that the mechanism of rotavirus diarrhea involves a general-
ized inhibition of symport systems and hence of water reab-
sorption. The resulting massive water loss through the intestine
would eventually contribute to overwhelming the organ’s ca-
pacity for water reabsorption, thereby facilitating establish-
ment of the main symptom of enteritis, diarrhea.
In this work, we investigated the hypothesis that NSP4 acts,
at least in part, by specifically inhibiting sodium-coupled solute
transport across the intestinal BBM. In particular, we exam-
ined whether NSP4(114-135) and certain related peptides
directly affect the kinetics of Na1 cotransport with either D-
glucose or L-leucine. To avoid possible problems of interpre-
tation, due for instance to indirect metabolic effects, changes in
intestinal structure, and/or changes in rotavirus protein synthe-
sis, transport was assayed with a rapid in vitro technique, based
on using jejunal BBM vesicles isolated from specific-pathogen-
free (SPF) young rabbits.
(A preliminary account of this work has been presented
elsewhere [2].)
MATERIALS AND METHODS
BBM vesicle preparation. SPF 4- and 7-week-old New Zealand albino hybrid
rabbits were obtained from Charles River. Jejunal segments from 7-week-old
rabbits and the entire small intestine from 4-week-old rabbits were removed,
rinsed with saline at room temperature, everted, and distributed into plastic bags
for storage at 280°C as described elsewhere (21).
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Intestinal BBM vesicles, prepared according to the magnesium precipitation
method of Hauser et al. (12), were suspended at about 40 mg of membrane
protein/ml in membrane buffer (20 mM HEPES–10 mM Tris HCl, supplemented
to a total osmolarity of 600 mosM with the inert sugar D-arabinose and adjusted
to pH 7.4 with Tris base [9, 21]) and stored in liquid nitrogen until the day of
assay, as described elsewhere (24). Membrane protein concentrations were mea-
sured with a Bio-Rad protein assay kit, using serum globulin as the standard.
Viral protein and synthetic peptides. The SA11 NSP4 protein and all peptides
used in this work were synthesized and purified as described elsewhere (5). They
were dissolved in the appropriate volume of membrane buffer to obtain either 8
mM protein or 10 mM peptide stock solutions, which were stored at 220°C until
use. The peptides used were Norwalk virus NV(464-483) (DTGRNLGEFKAYP
DGFLTCV), NSP4(114-135) (DKLTTREIEQVELLKRIYDKLT), and mNSP4
(131K) (DKLTTREIEQVELLKRIKDKLT).
Transport assay and expression of results. Transport was assayed by using a
rapid filtration technique and either D-[14C]glucose or L-[14C]leucine as the
substrate (7). BBM vesicle aliquots suspended in membrane buffer were mixed
with appropriate amounts of the same buffer containing either the intact protein
or a given peptide. After preincubation for 5 min at 35°C (unless stated other-
wise), 10-ml aliquots were used to carry out transport measurements by mixing
with 40 ml of transport buffer formed by membrane buffer supplemented with
either constant or variable (see below) concentrations of unlabeled substrate,
14C-labeled substrate as a tracer, and 100 mM sodium cyanide (all concentrations
given as the final ones in the incubation mixtures). Initial uptake rate measure-
ments were then carried out for 2.6 s at 35°C in an automatic, temperature-
controllable short-time incubation apparatus constructed in our laboratory. Up-
take data were statistically compared by applying a global one-way analysis of
variance (19). Results are shown as absolute uptake rates, v, in picomoles per
second per milligram of protein 6 standard deviation (SD).
Kinetic analyses. Uncorrected uptake rates as a function of either the sub-
strate (v 5 f[S] at [I] constant) or inhibitor (v 5 f[I] at [S] constant) concentration
were fitted by nonlinear least-squares regression analysis (23) to the appropriate
equation as indicated. To perform each fit, the procedure of Fletcher and Powell
as modified by van Melle and Robinson (23) was used. To test the fit of data to
each relevant equation, we used the commercial program Stata (Integral Soft-
ware, Paris, France). For statistical evaluation, fits were compared either within
each given condition (F test) or between pairs of conditions (F9 test) as described
elsewhere (23). For each given data set, comparison between a lack-of-fit and a
pure-error component, with the degrees of freedom given in that order in
parentheses in the tables, yielded F values that provide a quantitative assessment
of the goodness of fit. All individual F values listed in the tables were found to
be not significant, meaning that the data points did not differ statistically (P ,
0.01) from the theoretical fit of the equation used to perform the fit. This was
true for each of the curves forming each set, as well as for the overall fit of the
set. All calculations were done on Apple Macintosh microcomputers.
RESULTS
Effect of rotavirus NSP4 on intestinal BBM Na1-solute sym-
port activities in young rabbits. Jejunal BBM vesicles from
7-week-old rabbits were mixed with appropriate amounts of
purified NSP4. After incubation for 5 min at 35°C, aliquots
were used to assay uptake under standard conditions that in-
cluded a constant (0.1 mM) substrate concentration and a
zero-trans sodium cyanide gradient. Because of its low solubil-
ity, the maximal protein concentration that could be reached in
the incubation mixtures was 1 mM. This dose, however, was
found to be too low to have any significant effect on the uptake
of either D-glucose or L-leucine (results not shown). The ques-
tion posed having remained unanswered, we turned our atten-
tion to more soluble peptides derived from NSP4, some of
which have been shown to induce diarrhea in young rodents,
with kinetics similar to that of the intact protein (5).
Comparative effects of NSP4-related peptides on the kinet-
ics of D-glucose and L-leucine uptake by intestinal BBM vesi-
cles from young rabbits. In preliminary assays, we established
that doses in the order of 1 mM peptide were necessary to
cause significant effects on these symporters. This information
was then used to investigate the possible mode of action of
each of these peptides on intestinal transport, using first the
v 5 f [S] approach, at constant [I].
Saturation curves were performed with either D-glucose or
L-leucine as the substrate (Table 1). As previously established
TABLE 1. Comparative effects of NSP4-related peptides on the kinetics of D-glucose and L-leucine uptake by intestinal BBM vesicles from
young rabbitsa
Peptide (1 mM)
Kinetic parameter (mean 6 SD) F test
Vmax (pmol z s21 z mg of
membrane protein21) KT (mM)
Kd (nl z s21 z mg of
membrane protein21) F (df) F9
b
4-wk-old rabbits (substrate: D-Glucose)
Control 992 6 65 0.41 6 0.06 3.5 6 1.2 0.536 (8, 54) a
NV(464-483) 753 6 54 0.38 6 0.06 5.2 6 1.1 1.003 (7, 47) a
mNSP4(131K) 843 6 42 0.40 6 0.04 9.0 6 1.1 2.026 (8, 49) a
Overall fit 878 6 35 0.41 6 0.04 5.4 6 0.7 1.442 (8,171) a
NSP4(114-135) 165 6 20 0.53 6 0.12 5.1 6 0.8 1.422 (8, 50) b
7-wk-old rabbits
Substrate: D-Glucose
Control 389 6 38 0.42 6 0.09 4.9 6 1.1 0.864 (8, 49) a9
NV(464-483) 339 6 32 0.39 6 0.08 3.2 6 0.8 0.229 (8, 22) a9
mNSP4(131K) 223 6 24 0.37 6 0.08 2.9 6 0.7 2.148 (7, 17) a9
Overall fit 337 6 24 0.41 6 0.06 3.6 6 0.6 0.350 (9,108) a9
NSP4(114-135) 48 6 11 0.25 6 0.13 3.4 6 0.6 0.940 (6, 18) b9
Substrate: L-Leucine
Control 322 6 39 0.36 6 0.09 7.5 6 1.7 0.580 (11, 49) a0
NV(464-483) 270 6 32 0.31 6 0.08 5.5 6 1.5 0.493 (12, 73) a0
NSP4(114-135) 165 6 22 0.36 6 0.10 3.4 6 1.0 0.432 (10, 56) a0
Overall fit 248 6 21 0.36 6 0.06 5.2 6 0.9 0.500 (12,205) a0
a BBM vesicles from 4- or 7-week-old rabbits were mixed in the appropriate volume of membrane buffer in either the absence or presence of the indicated peptides,
calculated to give concentrations of 1 mM in the final (transport) incubation mixtures. After preincubation for 5 min at 35°C, aliquots were used to assay for either
D-glucose or L-leucine uptake as a function of [S], under standard conditions. Uncorrected uptake data were used to estimate the relevant kinetic parameters. For each
condition, F values were all found to be nonsignificant (see Materials and Methods).
b Letters identify fits that are statistical other (P , 0.01). Relevant data have been pooled and fitted again to yield the indicated overall fit values. For further details,
see text.
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with young rabbits (10), all uptake curves were found to fit an
equation involving the sum of one Michaelian, saturable trans-
port component and one nonsaturable, diffusion-like compo-
nent,
v 5 {[Vmax/(KT 1 [S])] 1 Kd}z[S] (1)
where Vmax and KT are, respectively, the capacity and affinity
parameters of classical Michaelis-Menten kinetics and Kd is an
apparent diffusion constant. Except for minor fluctuations that
fall within normal limits (9, 10), both KT and Kd remained
practically unchanged, regardless of the substrate used, the
peptide present in the transport assay, and the age of the
animals (average KT 5 0.38 6 0.11 [SD], n 5 610; average
Kd 5 5.1 6 2.2, n 5 610).
If the results are considered by groups, a similar conclusion
applies to Vmax, with the exception only of D-glucose. Thus, in
contrast with L-leucine, the D-glucose saturation curves ob-
tained in the presence of the NSP4(114-135) peptide are the
only ones found to be different by an F9 test (Table 1).
Because Kd remained constant under all conditions studied,
and because Kd is not merely a measure of the diffusion rate
but also can be interpreted as a function of the vesicular vol-
ume, that is, of the physical integrity of the vesicles (8), we
concluded that the apparent vesicular volume was constant,
meaning that there was no evidence of vesicle lysis in any of
these experiments. Because the preceding initial velocity ex-
periments involved very short (2.6-s) incubations, we also mea-
sured the vesicular volume after incubations for 90 min at
35°C. Again, Kd was found to remain constant, regardless of
the presence or absence of any of the NSP4-related peptides
used (data not shown). Taken as a whole, these results agree
with the observations of Tian et al. (20) indicating that even
though NSP4 and the NSP4(114-135) peptide have membrane
destabilization activity, this seems to be true only for liposomes
and endoplasmic reticulum vesicles, not for plasma membrane
vesicles such as the BBM vesicles used in the present work.
Because the integrity of the membrane was not affected, we
conclude that the observed inhibitions must have taken place
directly at the transport level.
Because the strong inhibitions caused by the NSP4(114-135)
peptide affected only the D-glucose transport Vmax (on the
average, 81 and 85% inhibition with 4- and 7-week-old ani-
mals, respectively), it can be concluded that this peptide acts as
a fully noncompetitive inhibitor of SGLT1. Interestingly, a
similar kinetic result, a selective inhibitory effect on the Vmax of
SGLT1, was obtained in in vivo studies of rotavirus infection of
young rabbits (10).
L-Leucine uptake was used as a control for a distinct but
mechanistically quite similar symport system, that of Na1 with
neutral amino acids. Although an effect of NSP4(114-135) on
L-leucine transport is suggested by the data in Table 1, the
results are borderline; that is, the control and NSP4(114-135)
curves were kinetically indistinguishable according to an F9 test
at P , 0.01. A significant difference was apparent when the
limits of probability were increased to P , 0.05, but no defin-
itive conclusion on this point could be reached. The existence
of a small inhibition of the Na1-L-leucine symporter by the
NSP4(114-135) peptide, although conceivable, can be consid-
ered to be quantitatively negligible compared with the strong
inhibition caused by this peptide on SGLT1.
The C-terminal Norwalk virus capsid, NV(464-483) peptide,
was tested as a possible negative control since this peptide does
not cause diarrhea even though it has physical properties quite
similar to those of NSP4(114-135), including a practically iden-
tical amphipathic score (5). The NV(464-483) peptide was
found to have a slight inhibitory effect on both D-glucose and
L-leucine transport (13 to 24% inhibition of Vmax). But again,
in both cases, an F9 test revealed no significant difference
compared to the control group. Interestingly, compared with
NSP4(114-135), the NV(464-483) peptide behaved essentially
in the same manner toward the Na1-L-leucine symporter,
agreeing with the results of peptide inhibition on leucine up-
take shown in Table 2. Obviously, such results strongly support
the conclusion that the effects of NSP4(114-135) on the D-
glucose symporter are indeed specific.
The third peptide investigated, mNSP4(131K), differs from
NSP4(114-135) only by having an L-lysine residue substituting
for the L-tyrosine at position 131. Similar to NV(464-483), the
mNSP4(131K) peptide had a slight effect on SGLT1, but once
again, this effect was not significant according to the F9 test at
P , 0.01 (Table 1). The fact that mNSP4(131K) neither inhib-
its SGLT1 nor causes diarrhea (5) is perhaps the best evidence
for the specificity of the NSP4(114-135) effect on D-glucose
transport mentioned above. We conclude that for SGLT1 in-
hibition to occur, the presence of an L-tyrosine in position 131
of the peptide is required. However, the question of why this
particular L-tyrosine is necessary for inhibition or, alterna-
tively, why the presence of a positively charged L-lysine in its
place blocks the inhibitory effect remains open.
Concerning the statistical relevance of the kinetic results
presented above, we propose the following considerations.
First, the total number of experimental points forming each
saturation curve (Table 1, df) is generally sufficient to obtain
statistically reliable fits to an equation (23). Second, even if
small quantitative differences are apparent, when taken by
groups (age of the animal, peptide, and substrate used), all of
the data are roughly equivalent. Hence, certain of the v 5 f[S]
results have been pooled into a single curve, such as those
listed as overall fits in Table 1 (e.g., upper curve in Fig. 1). As
mentioned, the only exceptions to this rule are the D-glucose
curves obtained in presence of the NSP4(114-135) peptide
(lower curve in Fig. 1). Finally, the fact that the D-glucose
transport results obtained for 4- and 7-week-old rabbits were
quantitatively equivalent reinforces the statistical validity of
this entire set of kinetic results.
Dose-dependent peptide effects on the Na1-solute symport-
ers. To confirm that the NSP4(114-135) effect on D-glucose
(but not on L-leucine) transport is indeed specific, experiments
were performed by using the v 5 f[I] approach, at a constant
(0.1 mM) concentration of each substrate.
(i) Effects on D-glucose uptake. With the NSP4(114-135)
peptide we found a progressive effect, approaching 78% inhi-
bition of the D-glucose symporter at 1 mM peptide (Fig. 2). A
significant but lesser inhibition was observed when the
NV(464-483) peptide was used (29% inhibition at 1 mM pep-
tide [Fig. 2]). However, the two curves have different shapes,
which can be taken as evidence that different transport path-
ways are involved, as discussed below.
Focusing on SGLT1, we considered whether the NSP4(114-
135) peptide inhibits preferentially from the outer (cis) or from
the inner (trans) side of the membrane. To answer this ques-
tion, right-side-out vesicles were treated with the peptide ini-
tially present only in the cis side, but half of the vesicle-plus-
peptide mixtures were subjected in parallel to two cycles of
freezing and thawing in liquid nitrogen to permit equilibration
of the peptide across the membrane (see reference 24 for the
rationale of this procedure). The D-glucose uptake rates were
found to be the same (Fig. 2), regardless of whether cis- or
cis-plus-trans conditions were used. This result can be inter-
preted in several ways. First, the peptide may act either pref-
erentially or exclusively from the external side of the mem-
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brane. Second, the amphipathic peptide can equilibrate rapidly
across the membrane, in which case freezing and thawing
would not be necessary to obtain a maximal effect if it acts
preferentially from the inner side. The most likely and simplest
interpretation is that the peptide is equally effective from ei-
ther side of the membrane.
To evaluate the stability of the peptide and whether the
inhibition was time dependent, we varied the time of contact
between peptide and membrane. Before assaying for transport,
vesicles were incubated with or without 0.4 mM (final concen-
tration) NSP4(114-135) peptide for time periods of 1, 5, 15,
and 30 min at 35°C. The D-glucose uptake rates were found to
remain constant, regardless of the time of preincubation. How-
ever, they were significantly different in either the absence
(174.5 6 28.7 pmol z s21 z mg of protein21, n 5 21) or presence
(127.9 6 21.5, n 5 21) of the peptide, indicating a 27% inhi-
bition. Quantitatively, this result agrees fully with that shown in
Fig. 2, indicating that (i) the effect is practically instantaneous
(it does not increase with time) and (ii) the peptide is stable.
This result proves that the observed inhibition does not involve
any NSP4 interference with the targeting of SGLT1 to the
BBM, a time-dependent process (incompatible with an instan-
taneous effect) that furthermore requires an intact cell and
would not occur with isolated BBM vesicles.
(ii) Hill equation analysis. Because of the shape of the
curves obtained, the results in Fig. 2 suggest strongly that an
empirical equation of the Hill type might be appropriate to
describe the observed peptide effects on D-glucose uptake (al-
though not necessarily those on L-leucine uptake). We there-
fore refitted this set of data by using an equation adapted from
Alvarado and Vasseur (3),
v 5 V/(1 1 {([I]/Ki)ni}) (2)
where V is an apparent maximal velocity; Ki is the apparent
affinity constant for the inhibitor, I (the peptide); and ni is the
Hill number. Nonlinear regression analysis of these data gave
the numerical results in Table 2. Both NV(464-483) and
NSP4(114-135) results could be fit very well by using equation
2, but the two curves were statistically different according to an
F9 test. The NSP4(114-135) peptide gave a Hill number larger
than 1 (ni 5 2.8), indicating the participation of at least three
peptide-binding sites in the interaction, each with an average
Ki of 0.67 mM. In contrast, the NV(464-483) peptide yielded a
Hill number of 1, with a lower affinity (Ki 5 1.7 mM), suggest-
ing that although NV(464-483) inhibits D-glucose uptake, the
effect is relatively small and probably involves a different mech-
anism that might be nonspecific.
(iii) Effects on L-leucine uptake. The most salient feature
of the L-leucine results is that both the NV(464-483) and
NSP4(114-135) peptides cause a practically identical, partial
inhibition of L-leucine uptake (Fig. 3; Table 2). Consequently,
because they are statistically indistinguishable, these data have
been pooled and fitted again to obtain the overall fit listed in
Table 2. As illustrated in Fig. 3, this result strongly suggests
that L-leucine symport inhibition is nonspecific and is not me-
diated by NSP4(114-135), a specific inhibitor of SGLT1. Anal-
ysis of the L-leucine results according to the Hill equation
(Table 2) reveals that the two peptides used, NV(464-483) and
FIG. 2. Dose-dependent effects of the NSP4(114-135) and NV(464-483) pep-
tides on the initial rate of D-glucose uptake by jejunal BBM vesicles from
7-week-old rabbits. Fixed amounts of vesicles were mixed with variable amounts
of peptide in the appropriate volume of membrane buffer to give the indicated
(final) peptide concentrations. These mixtures were either used directly (cis
peptide conditions) or subjected first to two cycles of freezing and thawing to
permit equilibration of the extra- and intravesicular contents (cis-plus-trans con-
ditions), as described elsewhere (24). After incubation for 5 min at 35°C, aliquots
were used to measure the initial rate of 0.1 mM D-glucose uptake under standard
conditions. Because the results at all given cis and cis-plus-trans peptide concen-
trations were statistically indistinguishable, they have been pooled and fitted
again to obtain relevant, overall fits. These are illustrated by the same symbol, F
for NSP4(114-135) and h for NV(464-483). Results are shown as absolute
substrate uptake rates 6 SD. The solid lines represent theoretical fits of either
set of data to equation 2, computed by using the kinetic parameters listed in
Table 2.
FIG. 1. Kinetic effects of NSP4-related peptides on D-glucose uptake by
intestinal BBM vesicles from 4-week-old rabbits. Initial rates of D-glucose up-
take, expressed as the uncorrected, absolute uptake rates, are plotted as a
function of substrate concentration in either the absence ( n ) or presence of 1
mM NV(464-483) (h), mNSP4(131K) (E), and NSP4(114-135) (F). Solid lines
represent theoretical fits computed by using the kinetic parameters listed in
Table 1. However, because the control, NV(464-483), and mNSP4(131K) results
were all statistically indistinguishable, they have been pooled and are shown as a
single curve corresponding to the overall fit for 4-week-old rabbits in Table 1.
The insert shows the results obtained by using only the lowest [D-glucose] range
used, 0.1 to 10 mM.
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NSP4(114-135), gave the same Hill number, 0.4. The fact that
these ni values are smaller than unity strongly indicates devi-
ation from simple Michaelian kinetics, as further discussed
below. Interestingly, such differences in the peptide effects on
the sodium-coupled transport of either D-glucose or L-leucine
strongly suggest that the two symporters do not use the same
mechanism.
Testing whether a three-site symport model can explain the
L-leucine and D-glucose transport inhibitions caused by NSP4-
related peptides. To test the preceding hypothesis, we reana-
lyzed the relevant data to see whether they can be explained in
terms of the three-site symport model recently proposed by
Alvarado and Vasseur to explain the interaction of another
BBM symport system, that of the enterocyte H1 and Cl2
symporter, with the amphipatic inhibitor carbonyl cyanide m-
chlorophenylhydrazone (4). According to this model, certain
Na1-solute cotransporters may involve a carrier, C, with three
distinct, specific binding sites: one for the substrate, S; one for
the allosteric activator, A (the Na1 ion); and a third for the
inhibitor, I (a peptide in the present paper). In the general
model, it is further assumed that all of the possible substrate-
bound carrier complexes, C-S, I5C-S, A5C-S, and IA5C-S,
can form and translocate. To use well-established jargon, the
model includes slippage; i.e., there is no need to propose that
the C-S complex is not mobile. Kinetically, the system is de-
fined by equation A1 in reference 4, that is,
v 5 @~V1 z @I#! 1 ~V2 z KI!#/~@I# 1 KI! (3)
where v is the total substrate uptake, V1 and V2 are two dis-
tinguishable maximal velocities resulting when [I] tends to in-
finity and zero, respectively; and KI is the apparent affinity
constant for I.
Accordingly, the L-leucine data in Fig. 3 were refitted by
using equation 3; the kinetic results are presented in Fig. 4 and
Table 3. It is clear that both equation 2 (Table 2; Fig. 3) and
equation 3 (Table 3; Fig. 4) fit the data satisfactorily; in both
cases, the results obtained with the NSP4(114-135) and
NV(464-483) peptides are statistically indistinguishable. This
result permitted a simpler analysis consisting of pooling the
data to obtain the overall fits listed in the tables. The experi-
mental data are of course the same, but the equations used to
TABLE 2. Kinetic parameters used to compute the theoretical curves in Fig. 2 and 3a
Substrate Peptide
Kinetic parameter (mean 6 SD) F test
V (pmolzs21 z mg of
membrane protein21) Ki (mM) ni F (df) F9
0.1 mM D-glucose NV(464-483) 106 6 4 1.69 6 0.42 1.1 6 0.4 0.903 (7,71) a
NSP4(114-135) 102 6 3 0.67 6 0.04 2.8 6 0.4 0.532 (6,80) b
0.1 mM L-leucine NV(464-483) 97 6 7 2.00 6 1.50 0.4 6 0.2 0.763 (7,22) a9
NSP4(114-135) 100 6 9 0.31 6 0.17 0.4 6 0.1 1.473 (6,56) a9
Overall fit 99 6 7 0.49 6 0.20 0.4 6 0.1 1.622 (7,87) a9
a Kinetic parameters for the function v 5 f [I] (at [S] constant 5 0.1 mM) were estimated by applying equation 2. Details for F and F9 tests are given in footnotes
to Table 1. The L-leucine results being statistically homogeneous, regardless of the peptide present, the relevant data have been pooled and fitted again to yield the
indicated overall fit values. Further details are given in the text.
FIG. 3. Dose-dependent effects of the NSP4(114-135) and NV(464-483) pep-
tides on the initial rate of L-leucine uptake by jejunal BBM vesicles from 7-week-
old rabbits. Details are as for Fig. 2, except for the use of L-leucine as the
substrate and peptides only in the cis side. Symbols: F, NSP4(114-135); h,
NV(464-483). Because the two peptides gave statistically indistinguishable re-
sults, the two sets of data have been pooled to obtain the overall fit in Table 2
(heavy middle line).
FIG. 4. Effect of the NSP4(114-135) peptide on the kinetics of L-leucine
uptake, according to the full, nonobligatory three-site symport model. Experi-
mental L-leucine data (taken from Fig. 3) were fitted by nonlinear regression
analysis to equation 3. The theoretical fits thus computed show the overall result
to be the sum (ct) of two distinct hyperbolas: one that is Michaelian (concave; c1)
and another that is convex (c2).
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perform each fit are different, as mentioned. As we shall show,
this difference is important, as it concerns interpretation of the
mechanisms involved.
The results show, first, that equation 3 yields the best fit, as
indicated by its lower F value (F 5 0.68 versus F 5 1.62 for
equation 2). Second and more important, equation 3 furnishes
meaningful information about the mechanism because it per-
mits separating the total uptake into two distinct components,
as defined by the general three-site model. Here, the two
components of equation 3 can be regarded as representing two
distinct pathways for leucine uptake, even when each of them
involves the same molecular entity, the three-site symporter
(4). The first pathway consists of a Michaelian concave hyper-
bola, [v1 5 V1 z [I]/([I] 1 KI)], and involves L-leucine fluxes via
the I5C-S and IA5C-S complexes (curve c1 in Fig. 4). The
second pathway consists of a convex hyperbola, [v2 5 V2 z K/([I]
1 KI)], and involves L-leucine fluxes via the C-S and A5C-S
complexes (curve c2 in Fig. 4). Thus, as [I] increases, fluxes via
these last two complexes will tend toward zero (curve c2),
whereas fluxes via the I5C-S and IA5C-S complexes will tend
to increase (curve c1). This means that at saturating [I] values,
Vmax will tend to V1, and v cannot possibly be zero. This is the
reason why these peptides inhibit L-leucine transport, but only
partially (Fig. 3). In conclusion, the mechanism of L-leucine
transport inhibition by the amphiphilic peptides can be ex-
plained in terms of the full, nonobligatory three-site symport
model in which all substrate-bound carrier complexes can form
and translocate. It seems conceivable that certain of the sub-
models previously described as special cases (4) could explain
the results even better. Such an analysis has not been at-
tempted here because it is not necessary: regardless of the
submodel used, the conclusion stated above would be valid.
When the same analysis was applied to the D-glucose uptake
data in Fig. 2, the results were quite different, agreeing with the
previous suggestion that this sugar and L-leucine use different
symport mechanisms. It is known (1, 16) that SGLT1 follows
an obligatory sodium activation mechanism according to
which, even though it can form, the C-S complex is not mobile;
only fluxes involving the IA5C-S and A5C-S complexes are
possible. When these D-glucose data were analyzed with equa-
tion 3, the fits all yielded a zero value for V1 (results not
illustrated), meaning that only equation 2 can fit these results.
Kinetically, such a result agrees fully with the conclusion stated
previously in this report that the NSP4(114-135) peptide is a
fully noncompetitive inhibitor of SGLT1. Summing up, apart
from the fact that the NSP4(114-135) peptide specifically in-
hibits D-glucose but not L-leucine transport, we conclude that
both substrates conform to the three-site symport model but
differ in one respect: whereas L-leucine fits the full, general
model where Na1 is a nonobligatory activator, D-glucose fol-
lows a restricted model where Na1 is an obligatory activator.
DISCUSSION
Our results show that in vitro, the NSP4(114-135) peptide
strongly and specifically inhibits the SGLT1 activity of intesti-
nal BBM vesicles from young rabbits. The Na1-L-leucine sym-
porter also is inhibited (Fig. 3), but this effect is much weaker
and probably nonspecific. Indeed, it seems conceivable that
this effect involves nonspecific, lipophilic interactions of the
amphipathic peptides with the membrane.
Interestingly, in in vivo experiments with young rabbits in-
fected either naturally or experimentally with a lapine rotavi-
rus, La/RR510 strain, the Na1-L-leucine symporter was inhib-
ited strongly and to an extent similar to that of SGLT1. In both
cases, Vmax was the only kinetic parameter impaired after ro-
tavirus infection (10). Because with D-glucose qualitatively and
quantitatively similar effects are obtained, either during rota-
virus infection in vivo (10) or in in vitro experiments with
isolated NSP4 peptides (this report), the in vitro effects exhib-
ited by certain NSP4-related peptides on SGLT1 might explain
the rotavirus transport effects observed in vivo.
The case of L-leucine appears to be special. In contrast with
the in vivo experiments just mentioned, the Na1-L-leucine
symport activity was not significantly inhibited when the iso-
lated NSP4(114-135) peptide was used directly (Table 1). Such
a result strongly suggests that if rotavirus infection results in
inhibition of the Na1-L-leucine symporter, this inhibition, in
contrast with that of the SGLT1, is unlikely to be mediated by
the NSP4(114-135) peptide. More work will be required to
establish whether or not the Na1-L-leucine symporter inhibi-
tion is caused by some other rotavirus protein or by some NSP4
peptide distinct from NSP4(114-135).
The concentrations of NSP4(114-135) that cause full inhibi-
tion of SGLT1, about 1 mM according to the data presented
here, are of the same order of magnitude as those used by Ball
et al. (5) to induce diarrhea in young rodents. In these exper-
iments, both intraperitoneal and intraduodenal NSP4(114-135)
peptide were effective, but only in young (6- to 8-day-old) mice.
Peptide administration to slightly older (11- to 13-day-old)
animals was much less effective. Our experiments were carried
out by using vesicles from either 4- or 7-week-old rabbits. The
possibility clearly exists that stronger effects may have been
obtained if younger rabbits had been used. But such work was
not attempted at this time, mainly because working with SPF
rabbits younger than 4 weeks would have posed practical prob-
lems of availability.
The very low concentration of the NSP4 protein that can be
maintained in the incubation mixtures (1 mM) was found to
have no significant effect on the uptake of either D-glucose or
L-leucine. Such a result was not surprising because to induce
diarrhea in young rodents (5), doses as high as 2 mM were
necessary. However, the validity of comparing biologically ef-
fective doses derived from either in vivo or in vitro work ap-
pears to be limited (25).
TABLE 3. Kinetic parameters used to compute the theoretical curves in Fig. 4
Peptide
Kinetic parameter F testa
V1 (pmol z s21 z mg of
membrane protein21)
V2 (pmol z s21 z mg of
membrane protein21) KI (mM) F (df) F9
NV(464-483) 54 6 5 98 6 7 0.062 6 0.05 0.491 (7,22) a
NSP4(114-135) 37 6 3 100 6 8 0.050 6 0.02 0.540 (6,56) a
Overall fit 41 6 3 99 6 6 0.057 6 0.02 0.675 (7,87) a
a See footnotes to Table 1. Further details are provided in the text.
VOL. 74, 2000 ROTAVIRUS PEPTIDES AND INTESTINAL Na1-SOLUTE SYMPORTS 9469
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
The specific and strong inhibition caused in vitro by the
NSP4(114-135) peptide on SGLT1 strongly suggests that this
effect can be one (but not necessarily the only) important
factor in the pathogenesis of rotavirus diarrhea. Based on our
in vivo work with rotavirus-infected rabbits (10), we proposed
earlier that a generalized inhibition of Na1-solute cotransport
systems might be at the basis of the inhibition of intestinal
water reabsorption caused by rotavirus in the absence of any
histological damage to the intestinal mucosa. The subsequent
massive water loss might eventually overwhelm the intestinal
capacity for water reabsorption, thereby contributing to estab-
lishment of the main symptom of enteritis, diarrhea (10).
The fact that the mNSP4(131K) peptide does not inhibit
SGLT1 constitutes perhaps the strongest evidence for our con-
clusion that the specific inhibition of this cotransporter is a key
factor in the pathogenesis of rotavirus diarrhea. In closing, we
have established the existence of the following correlation:
NSP4(114-135) inhibits SGLT1 and causes diarrhea, whereas
mNSP4(131K) neither inhibits SGLT1 nor causes diarrhea.
Concerning the possible role of NSP4 in the pathogenesis of
rotavirus diarrhea, the present in vitro work strongly suggests
that NSP4 is at least one among other effectors directly causing
SGLT1 inhibition during rotavirus infection in vivo. Whereas
in vitro NSP4(114-135) inhibits SGLT1 practically instanta-
neously, the situation in vivo is different. Being absent from the
mature, infective virion particle, the nonstructural protein
NSP4 needs to be synthesized after infection, and time will be
required for the newly synthesized protein to be released into
the cytoplasm and/or the intestinal lumen and migrate to its
target, the symporter molecule.
ACKNOWLEDGMENTS
This work was supported in part by the Institut National de la Sante´
et de la Recherche Me´dicale (INSERM); the Fondation pour la Re-
cherche Me´dicale, Paris; the Association Franc¸aise de Lutte contre la
Mucoviscidose (AFLM); the INCO Program of the European Eco-
nomic Community (grant ERB 3514 PL 950019); the Ministe`re Fran-
c¸ais de l’Education Nationale, de la Recherche et de la Technologie
(grant MENRT-PRFMMIP); and the National Institutes of Health
(grant DK 30144).
REFERENCES
1. Alvarado, F., E. Brot-Laroche, B. Delhomme, M. A. Serrano, and S. Sup-
plisson. 1986. Heterogeneity of sodium-activated D-glucose transport sys-
tems in the intestinal brush-border membrane: physiological implications.
Boll. Soc. Ital. Biol. Sper. 62:110–132.
2. Alvarado, F., N. Halaihel, J. M. Ball, M. K. Estes, and M. Vasseur. 1998.
Rotavirus nonstructural glycoprotein NSP4 abolishes SGLT1 activity of
brush border membrane vesicles from rabbit jejunum. Z. Gastroenterol.
36:326.
3. Alvarado, F., and M. Vasseur. 1996. Theoretical and experimental discrim-
ination between Cl2-H1 symporters and Cl2/OH2 antiporters. Am. J.
Physiol. 271:C1612–C1628.
4. Alvarado, F., and M. Vasseur. 1998. Direct inhibitory effect of CCCP on the
Cl2-H1 symporter of the guinea pig ileal brush-border membrane. Am. J.
Physiol. 274:C481–C491.
5. Ball, J. M., P. Tian, C. Q.-Y. Zeng, A. P. Morris, and M. K. Estes. 1996.
Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.
Science 272:101–104.
6. Bridger, J. C., G. A. Hall, and K. R. Parsons. 1992. A study of the basis of
virulence variation of bovine rotaviruses. Vet. Microbiol. 33:169–174.
7. Brot-Laroche, E., M. A. Serrano, B. Delhomme, and F. Alvarado. 1986.
Temperature sensitivity and substrate specificity of two distinct Na1-acti-
vated D-glucose transport systems in guinea-pig jejunal brush border mem-
brane vesicles. J. Biol. Chem. 261:6168–6176.
8. Brot-Laroche, E., and F. Alvarado. 1984. Disaccharide uptake by brush-
border membrane vesicles lacking the corresponding hydrolases. Biochim.
Biophys. Acta 775:175–181.
9. Halaihel, N., D. Gerbaud, M. Vasseur, and F. Alvarado. 1999. Heterogeneity
of pig intestinal D-glucose transport systems. Am. J. Physiol. 277:C1130–
C1141.
10. Halaihel, N., V. Lie´vin, F. Alvarado, and M. Vasseur. Rotavirus infection
impairs intestinal brush border membrane Na1-solute symport activity in
young rabbits. Am. J. Physiol., in press.
11. Hamilton, J. R. 1988. Viral enteritis. Pediatr. Clin. North Am. 35:89–101.
12. Hauser, H., K. Howell, R. M. C. Dawson, and D. E. Boyer. 1980. Rabbit small
intestinal brush border membrane preparation and lipid composition. Bio-
chim. Biophys. Acta 602:567–577.
13. Jourdan, N., J. P. Brunet, C. Sapin, A. Blais, J. Cotte-Laffitte, F. Forestier,
A. M. Quero, G. Trugnan, and A. L. Servin. 1998. Rotavirus infection
reduces sucrase-isomaltase expression in human intestinal epithelial cells by
perturbing protein targeting and organization of microvillar cytoskeleton.
J. Virol. 72:7228–7236.
14. Loo, D. D. F., T. Zeuthen, G. Chandy, and E. M. Wright. 1996. Cotransport
of water by the Na1/glucose cotransporter. Proc. Natl. Acad. Sci. USA
93:13367–13370.
15. MacLeod, R. J., and J. R. Hamilton. 1987. Absence of a cAMP-mediated
anti-absorptive effect in an undifferentiated jejunal epithelium. Am. J.
Physiol. 252:G776–G782.
16. Parent, L., S. Supplisson, D. D. Loo, and E. M. Wright. 1992. Electrogenic
properties of the cloned Na1/glucose cotransporter. II. A transport model
under nonrapid equilibrium conditions. J. Membr. Biol. 130:203.
17. Ramig, R. F. 1988. The effects of host age, virus dose, and virus strain on
heterologous rotavirus infection of suckling mice. Microb. Pathog. 4:189–
202.
18. Shaw, R. D., S. J. Hempson, and E. R. Mackow. 1995. Rotavirus diarrhea is
caused by nonreplicating viral particles. J. Virol. 69:5946–5950.
19. Snedecor, G. W., and W. G. Cochran. 1967. Statistical methods, 6th ed. Iowa
State Press, Ames, Iowa.
20. Tian, P., J. M. Ball, C. Q. Y. Zeng, and M. K. Estes. 1996. The rotavirus
nonstructural glycoprotein NSP4 possesses membrane destabilization activ-
ity. J. Virol. 70:6973–6981.
21. Touzani, K., M. Cau˜zac, M. Vasseur, and F. Alvarado. 1994. Rheogenic Cl2
conductance and Cl2-Cl2 exchange activities in guinea pig jejunal basolat-
eral membrane vesicles. Am. J. Physiol. 266:G271–G281.
22. Tzipori, S., L. Unicomb, R. Bishop, J. Montenaro, and L. M. Vaelioja. 1989.
Studies on attenuation of rotavirus. A comparison in piglets between virulent
virus and its attenuated derivative. Arch. Virol. 109:197–205.
23. van Melle, G., and J. W. L. Robinson. 1981. Systematic approach to the
analysis of intestinal transport kinetics. J. Physiol. 77:1011–1016.
24. Vasseur, M., M. Cau˜zac, and F. Alvarado. 1989. Electroneutral, HCO32-
independent, pH gradient-dependent uphill transport of Cl2 by brush-bor-
der membrane vesicles. Possible role in the pathogenesis of chloridorrhea.
Biochem. J. 263:775–784.
25. Zhang, M., C. Q.-Y. Zeng, Y. Dong, J. M. Ball, L. J. Saif, A. P. Morris, and
M. K. Estes. 1998. Mutations in rotavirus nonstructural glycoprotein NSP4
are associated with altered virulence. J. Virol. 72:3666–3672.
9470 HALAIHEL ET AL. J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
